Imaging in interventional oncology

Radiology

Volumn 257, Issue 3, 2010, Pages 624-640

  Solomon, Stephen B ^a   Silverman, Stuart G ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN TC 99M; CONTRAST MEDIUM; FLUORODEOXYGLUCOSE F 18;

ARTIFICIAL EMBOLISM; BRACHYTHERAPY; CANCER RADIOTHERAPY; CLINICAL ASSESSMENT; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTED TOMOGRAPHY SCANNER; DIAGNOSTIC IMAGING; DOPPLER FLOWMETRY; ECHOGRAPHY; FEASIBILITY STUDY; HUMAN; IMAGE DISPLAY; IMAGE QUALITY; IMAGE RECONSTRUCTION; INTERVENTIONAL ONCOLOGY; INTERVENTIONAL RADIOLOGY; MATHEMATICAL MODEL; MOLECULAR IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOLOGY; PHYSICIAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION EXPOSURE; RADIODIAGNOSIS; REAL TIME ECHOGRAPHY; REVIEW; ROBOTICS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPECTROSCOPY; THREE DIMENSIONAL IMAGING; TREATMENT PLANNING; TUMOR ABLATION; TUMOR GROWTH; X RAY FLUORESCENCE;

EID: 78649644675     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.10081490     Document Type: Review

References (158)

1. Silverman SG, Deuson TE, Kane NM, et al. Percutaneous abdominal biopsy: cost-identification analysis. Radiology 1998;206(2):429-435.
2. Link RE, Permpongkosol S, Gupta A, Jarrett TW, Solomon SB, Kavoussi LR. Cost analysis of open, laparoscopic, and percutaneous treatment options for nephron-sparing surgery. J Endourol 2006;20(10):782-789.
3. Gazelle GS, McMahon PM, Beinfeld MT, Halpern EF, Weinstein MC. Metastatic colorectal carcinoma: cost-effectiveness of percutaneous radiofrequency ablation versus that of hepatic resection. Radiology 2004; 233(3):729-739.
4. Silverman SG, Collick BD, Figueira MR, et al. Interactive MR-guided biopsy in an open-configuration MR imaging system. Radiology 1995;197(1):175-181.
5. Silverman SG, Jolesz FA, Newman RW, et al. Design and implementation of an interventional MR imaging suite. AJR Am J Roentgenol 1997;168(6):1465-1471.
6. Goldberg SN, Charboneau JW, Dodd GD 3rd, et al. Image-guided tumor ablation: proposal for standardization of terms and reporting criteria. Radiology 2003;228(2):335-345.
7. Jolesz FA, Blumenfeld SM. Interventional use of magnetic resonance imaging. Magn Reson Q 1994;10(2):85-96.
8. Mageras GS, Mechalakos J. Planning in the IGRT context: closing the loop. Semin Radiat Oncol 2007;17(4):268-277.
9. Solomon SB, Patriciu A, Stoianovici DS. Tumor ablation treatment planning coupled to robotic implementation: a feasibility study. J Vasc Interv Radiol 2006;17(5):903-907.
10. Khajanchee YS, Streeter D, Swanstrom LL, Hansen PD. A mathematical model for preoperative planning of radiofrequency ablation of hepatic tumors. Surg Endosc 2004;18(4):696-701.
11. Jankun M, Kelly TJ, Zaim A, et al. Computer model for cryosurgery of the prostate. Comput Aided Surg 1999;4(4):193-199.
12. Villard C, Baegert C, Schreck P, Soler L, Gangi A. Optimal trajectories computation within regions of interest for hepatic RFA planning. Med Image Comput Comput Assist Interv 2005;8(pt 2):49-56.
13. Sze DY, Razavi MK, So SK, Jeffrey RB Jr. Impact of multidetector CT hepatic arteriography on the planning of chemoembolization treatment of hepatocellular carcinoma. AJR Am J Roentgenol 2001;177(6):1339-1345.
14. Basile A, Tsetis D, Montineri A, et al. MDCT anatomic assessment of right inferior phrenic artery origin related to potential supply to hepatocellular carcinoma and its embolization. Cardiovasc Intervent Radiol 2008;31(2):349-358.
15. Denecke T, Rühl R, Hildebrandt B, et al. Planning transarterial radioembolization of colorectal liver metastases with Yttrium 90 microspheres: evaluation of a sequential diagnostic approach using radiologic and nuclear medicine imaging techniques. Eur Radiol 2008;18(5):892-902.
16. Ho S, Lau WY, Leung TW, Chan M, Johnson PJ, Li AK. Clinical evaluation of the partition model for estimating radiation doses from yttrium-90 microspheres in the treatment of hepatic cancer. Eur J Nucl Med 1997;24(3):293-298.
17. Deschamps F, Solomon SB, Thornton RH, et al. Computed analysis of three dimensional cone-beam computed tomography angiography for determination of tumor-feeding vessels during chemoembolization of liver tumor: a pilot study. Cardiovasc Intervent Radiol 2010 Apr 14. [Epub ahead of print].
18. Torigian DA, Huang SS, Houseni M, Alavi A. Functional imaging of cancer with emphasis on molecular techniques. Cancer 2007; 57(4):206-224.
19. Yang YJ, Ryu JS, Kim SY, et al. Use of 3′- deoxy-3′-[18F] fluorothymidine PET to monitor early responses to radiation therapy in murine SCCVII tumors. Eur J Nucl Med Mol Imaging 2006;33(4):412-419.
20. Beer AJ, Grosu AL, Carlsen J, et al. [18F] galacto-RGD positron emission tomography for imaging of alphavbeta3 expression on the neovasculature in patients with squamous cell carcinoma of the head and neck. Clin Cancer Res 2007;13(22 pt 1):6610-6616.
21. Arias-Mendoza F, Smith MR, Brown TR. Predicting treatment response in non- Hodgkin's lymphoma from the pretreatment tumor content of phosphoethanolamine plus phosphocholine. Acad Radiol 2004;11(4): 368-376.
22. Villard C, Soler L, Gangi A. Radiofrequency ablation of hepatic tumors: simulation, planning, and contribution of virtual reality and haptics. Comput Methods Biomech Biomed Engin 2005;8(4):215-227.
23. Villard PF, Vidal FP, Hunt C, et al. A prototype percutaneous transhepatic cholangiography training simulator with real-time breathing motion. Int J CARS 2009;4(6): 571-578.
24. Dawson S. Procedural simulation: a primer. J Vasc Interv Radiol 2006;17(2 pt 1):205-213.
25. Lendvay TS, Hsieh FJ, Hannaford B, Rosen J. The biomechanics of percutaneous needle insertion. Stud Health Technol Inform 2008; 132:245-247.
26. Silverman SG, Tuncali K, Adams DF, Nawfel RD, Zou KH, Judy PF. CT fluoroscopy-guided abdominal interventions: techniques, results, and radiation exposure. Radiology 1999; 212(3):673-681.
27. Nawfel RD, Judy PF, Silverman SG, Hooton S, Tuncali K, Adams DF. Patient and personnel exposure during CT fluoroscopy-guided interventional procedures. Radiology 2000; 216(1):180-184.
28. Lewin JS, Nour SG, Connell CF, et al. Phase II clinical trial of interactive MR imaging-guided interstitial radiofrequency thermal ablation of primary kidney tumors: initial experience. Radiology 2004;232(3):835-845.
29. Tatli S, Morrison PR, Tuncali K, Silverman SG. Interventional MRI for oncologic applications. Tech Vasc Interv Radiol 2007;10(2): 159-170.
30. de Mey J, Op de Beeck B, Meysman M, et al. Real time CT-fluoroscopy: diagnostic and therapeutic applications. Eur J Radiol 2000;34(1):32-40.
31. Yamao Y, Yamakado K, Takaki H, et al. Optimal scan parameters for CT fluoroscopy in lung interventional radiologic procedures: relationship between radiation dose and image quality. Radiology 2010;255(1):233-241.
32. Hohl C, Suess C, Wildberger JE, et al. Dose reduction during CT fluoroscopy: phantom study of angular beam modulation . Radiology 2008;246(2):519-525.
33. Irie T, Kajitani M, Itai Y. CT fluoroscopy-guided intervention: marked reduction of scattered radiation dose to the physician's hand by use of a lead plate and an improved I-I device. J Vasc Interv Radiol 2001;12(12): 1417-1421.
34. Yutzy SR, Duerk JL. Pulse sequences and system interfaces for interventional and real-time MRI. J Magn Reson Imaging 2008; 27(2):267-275.
35. Saybasili H, Faranesh AZ, Saikus CE, Ozturk C, Lederman RJ, Guttman MA. Interventional MRI using multiple 3D angiography roadmaps with real-time imaging. J Magn Reson Imaging 2010;31(4):1015-1019.
36. Puls R, Langner S, Rosenberg C, et al. Laser ablation of liver metastases from colorectal cancer with MR thermometry: 5-year survival. J Vasc Interv Radiol 2009; 20(2):225-234.
37. Pech M, Wieners G, Freund T, et al. MR-guided interstitial laser thermotherapy of colorectal liver metastases: efficiency, safety and patient survival. Eur J Med Res 2007; 12(4):161-168.
38. Mougenot C, Quesson B, de Senneville BD, et al. Three-dimensional spatial and temporal temperature control with MR thermometry-guided focused ultrasound (MRgHIFU). Magn Reson Med 2009;61(3):603-614.
39. Silverman SG, Tuncali K, Morrison PR. MR imaging-guided percutaneous tumor ablation. Acad Radiol 2005;12(9):1100-1109.
40. Silverman SG, Tuncali K, Adams DF, et al. MR imaging-guided percutaneous cryotherapy of liver tumors: initial experience. Radiology 2000;217(3):657-664.
41. Gedroyc WM. Magnetic resonance guidance of thermal ablation. Top Magn Reson Imaging 2005;16(5):339-353.
42. Roujol S, Ries M, Quesson B, Moonen C, Denis de Senneville B. Real-time MR-thermometry and dosimetry for interventional guidance on abdominal organs. Magn Reson Med 2010;63(4):1080-1087.
43. Morrison PR, Silverman SG, Tuncali KT, Tatli S. MRI-guided cryotherapy. J Magn Reson Imaging 2008;27(2):410-420.
44. Boss A, Clasen S, Kuczyk M, et al. Magnetic resonance-guided percutaneous radio-frequency ablation of renal cell carcinomas: a pilot clinical study. Invest Radiol 2005; 40(9):583-590.
45. Fritz J, Clasen S, Boss A, et al. Real-time MR fluoroscopy-navigated lumbar facet joint injections: feasibility and technical properties. Eur Radiol 2008;18(7):1513-1518.
46. Stattaus J, Maderwald S, Forsting M, Barkhausen J, Ladd ME. MR-guided core biopsy with MR fluoroscopy using a short, wide-bore 1.5-Tesla scanner: feasibility and initial results. J Magn Reson Imaging 2008; 27(5):1181-1187.
47. Moelker A, Maas RA, Lethimonnier F, Pattynama PM. Interventional MR imaging at 1.5 T: quantification of sound exposure. Radiology 2002;224(3):889-895.
48. Moelker A, Wielopolski PA, Pattynama PM. Relationship between magnetic field strength and magnetic-resonance-related acoustic noise levels. MAGMA 2003;16(1): 52-55.
49. Nour SG, Lewin JS. Radiofrequency thermal ablation: the role of MR imaging in guiding and monitoring tumor therapy. Magn Reson Imaging Clin N Am 2005;13(3):561-581.
50. Weiss CR, Nour SG, Lewin JS. MR-guided biopsy: a review of current techniques and applications. J Magn Reson Imaging 2008; 27(2):311-325.
51. Smits HF, Bos C, van der Weide R, Bakker CJ. Interventional MR: vascular applications. Eur Radiol 1999;9(8):1488-1495.
52. Wallace MJ. C-arm computed tomography for guiding hepatic vascular interventions. Tech Vasc Interv Radiol 2007;10(1):79-86.
53. Liapi E, Hong K, Georgiades CS, Geschwind JF. Three-dimensional rotational angiography: introduction of an adjunctive tool for successful transarterial chemoembolization. J Vasc Interv Radiol 2005;16(9):1241-1245.
54. Beldi G, Styner M, Schindera S, Inderbitzin D, Candinas D. Intraoperative three-dimensional fluoroscopic cholangiography. Hepatogastroenterology 2006;53(68):157-159.
55. Kakeda S, Korogi Y, Ohnari N, et al. Usefulness of cone-beam volume CT with flat panel detectors in conjunction with catheter angiography for transcatheter arterial embolization. J Vasc Interv Radiol 2007; 18(12):1508-1516.
56. Solomon SB, Thornton R, Deschamps F, et al. A treatment planning system for transcatheter hepatic therapies: pilot study. J Interv Oncol 2008;1:12-18.
57. Morimoto M, Numata K, Kondo M, et al. C-arm cone beam CT for hepatic tumor ablation under real-time 3D imaging. AJR Am J Roentgenol 2010;194(5):W452-W454.
58. Xu F, Mueller K. Real-time 3D computed tomographic reconstruction using commodity graphics hardware. Phys Med Biol 2007; 52(12):3405-3419. (Pubitemid 46830633)
59. Silverman SG, Sun MRM, Tuncali K, et al. Three-dimensional assessment of MRI-guided percutaneous cryotherapy of liver metastases. AJR Am J Roentgenol 2004;183(3): 707-712.
60. Antoch G, Kuehl H, Vogt FM, Debatin JF, Stattaus J. Value of CT volume imaging for optimal placement of radiofrequency ablation probes in liver lesions. J Vasc Interv Radiol 2002;13(11):1155-1161.
61. Chin JL, Downey DB, Onik G, Fenster A. Three-dimensional prostate ultrasound and its application to cryosurgery. Tech Urol 1996;2(4):187-193. (Pubitemid 27137437)
62. Chen MH, Yang W, Yan K, et al. The role of contrast-enhanced ultrasound in planning treatment protocols for hepatocellular carcinoma before radiofrequency ablation. Clin Radiol 2007;62(8):752-760.
63. Solbiati L, Ierace T, Tonolini M, Cova L. Guidance and monitoring of radiofrequency liver tumor ablation with contrast-enhanced ultrasound. Eur J Radiol 2004;51(suppl): S19-S23.
64. Numata K, Isozaki T, Ozawa Y, et al. Percutaneous ablation therapy guided by contrast-enhanced sonography for patients with hepatocellular carcinoma. AJR Am J Roentgenol 2003;180(1):143-149.
65. Liu JB, Wansaicheong G, Merton DA, et al. Canine prostate: contrast-enhanced US-guided radiofrequency ablation with urethral and neurovascular cooling - initial experience. Radiology 2008;247(3):717-725.
66. Fu Y, Nitecki DE, Maltby D, et al. Dendritic iodinated contrast agents with PEG-cores for CT imaging: synthesis and preliminary characterization. Bioconjug Chem 2006; 17(4):1043-1056.
67. Zheng J, Allen C, Serra S, Vines D, Charron M, Jaffray DA. Liposome contrast agent for CT-based detection and localization of neoplastic and inflammatory lesions in rabbits: validation with FDG-PET and histology. Contrast Media Mol Imaging 2010;5(3):147-154.
68. Burtea C, Laurent S, Vander Elst L, Muller RN. Contrast agents: magnetic resonance. Handb Exp Pharmacol 2008;185(185 pt 1): 135-165.
69. Bartolozzi C, Crocetti L, Lencioni R, Cioni D, Della Pina C, Campani D. Biliary and reticuloendothelial impairment in hepatocarcinogenesis: the diagnostic role of tissue-specific MR contrast media. Eur Radiol 2007;17(10):2519-2530.
70. Needham D, Dewhirst MW. The development and testing of a new temperature-sensitive drug delivery system for the treatment of solid tumors. Adv Drug Deliv Rev 2001;53(3):285-305.
71. McDannold N, Fossheim SL, Rasmussen H, Martin H, Vykhodtseva N, Hynynen K. Heat-activated liposomal MR contrast agent: initial in vivo results in rabbit liver and kidney. Radiology 2004;230(3):743-752.
72. Lindner LH, Reinl HM, Schlemmer M, Stahl R, Peller M. Paramagnetic thermo-sensitive liposomes for MR-thermometry. Int J Hyperthermia 2005;21(6):575-588.
73. Wendler T, Traub J, Ziegler SI, Navab N. Navigated three dimensional beta probe for optimal cancer resection. Med Image Comput Comput Assist Interv 2006;9(pt 1): 561-569.
74. Strong VE, Humm J, Russo P, et al. A novel method to localize antibody-targeted cancer deposits intraoperatively using hand-held PET beta and gamma probes. Surg Endosc 2008;22(2):386-391.
75. Wu AM, Olafsen T. Antibodies for molecular imaging of cancer. Cancer J 2008;14(3): 191-197.
76. Yap JT, Carney JP, Hall NC, Townsend DW. Image-guided cancer therapy using PET/CT. Cancer J 2004;10(4):221-233.
77. Veit P, Kuehle C, Beyer T, Kuehl H, Bockisch A, Antoch G. Accuracy of combined PET/CT in image-guided interventions of liver lesions: an ex-vivo study. World J Gastroenterol 2006;12(15):2388-2393.
78. Heron DE, Smith RP, Andrade RS. Advances in image-guided radiation therapy: the role of PET-CT. Med Dosim 2006;31(1): 3-11.
79. Giesel FL, Mehndiratta A, Locklin J, et al. Image fusion using CT, MRI and PET for treatment planning, navigation and follow up in percutaneous RFA. Exp Oncol 2009; 31(2):106-114.
80. Crocetti L, Lencioni R, Debeni S, See TC, Pina CD, Bartolozzi C. Targeting liver lesions for radiofrequency ablation: an experimental feasibility study using a CT-US fusion imaging system. Invest Radiol 2008; 43(1):33-39.
81. Wein W, Röper B, Navab N. Automatic registration and fusion of ultrasound with CT for radiotherapy. Med Image Comput Comput Assist Interv 2005;8(pt 2):303-311.
82. Archip N, Tatli S, Morrison P, Jolesz F, Warfield SK, Silverman SG. Non-rigid registration of pre-procedural MR images with intra-procedural unenhanced CT images for improved targeting of tumors during liver radiofrequency ablations. Med Image Comput Comput Assist Interv 2007;10(pt 2):969-977.
83. Gutiérrez LF, Silva R, Ozturk C, et al. Technology preview: x-ray fused with magnetic resonance during invasive cardiovascular procedures. Catheter Cardiovasc Interv 2007;70(6):773-782.
84. Solomon SB. Incorporating CT, MR imaging, and positron emission tomography into minimally invasive therapies. J Vasc Interv Radiol 2005;16(4):445-447.
85. Cleary K, Zhang H, Glossop N, Levy E, Wood B, Banovac F. Electromagnetic tracking for image-guided abdominal procedures: overall system and technical issues. Conf Proc IEEE Eng Med Biol Soc 2005;7:6748-6753.
86. Meyer BC, Peter O, Nagel M, et al. Electromagnetic field-based navigation for percutaneous punctures on C-arm CT: experimental evaluation and clinical application. Eur Radiol 2008;18(12):2855-2864.
87. Braak SJ, van Strijen MJ, van Leersum M, van Es HW, van Heesewijk JP. Real-time 3D fluoroscopy guidance during needle interventions: technique, accuracy, and feasibility. AJR Am J Roentgenol 2010;194(5): W445-W451.
88. Zhang H, Banovac F, Lin R, et al. Electromagnetic tracking for abdominal interventions in computer aided surgery. Comput Aided Surg 2006;11(3):127-136.
89. Solomon SB. Interactive images in the operating room. J Endourol 1999;13(7):471-475.
90. Mogami T, Dohi M, Harada J. A new image navigation system for MR-guided cryosurgery. Magn Reson Med Sci 2002;1(4):191-197.
91. Borgert J, Krüger S, Timinger H, et al. Respiratory motion compensation with tracked internal and external sensors during CTguided procedures. Comput Aided Surg 2006;11(3):119-125.
92. Peters TM. Image-guidance for surgical procedures. Phys Med Biol 2006;51(14): R505-R540.
93. Wood BJ, Locklin JK, Viswanathan A, et al. Technologies for guidance of radiofrequency ablation in the multimodality interventional suite of the future. J Vasc Interv Radiol 2007;18(1 pt 1):9-24.
94. Marohn MR, Hanly EJ. Twenty-first century surgery using twenty-first century technology: surgical robotics. Curr Surg 2004;61(5): 466-473.
95. Solomon SB, Patriciu A, Bohlman ME, Kavoussi LR, Stoianovici D. Robotically driven interventions: a method of using CT fluoroscopy without radiation exposure to the physician. Radiology 2002;225(1):277-282.
96. Cleary K, Melzer A, Watson V, Kronreif G, Stoianovici D. Interventional robotic systems: applications and technology state-of-the-art. Minim Invasive Ther Allied Technol 2006;15(2):101-113.
97. Hempel E, Fischer H, Gumb L, et al. An MRI-compatible surgical robot for precise radiological interventions. Comput Aided Surg 2003;8(4):180-191.
98. Stoianovici D. Multi-imager compatible actuation principles in surgical robotics. Int J Med Robot 2005;1(2):86-100.
99. Boctor EM, Choti MA, Burdette EC, Webster Iii RJ. Three-dimensional ultrasound-guided robotic needle placement: an experimental evaluation. Int J Med Robot 2008; 4(2):180-191.
100. DiMaio SP, Pieper S, Chinzei K, et al. Robot-assisted needle placement in open MRI: system architecture, integration and validation. Comput Aided Surg 2007;12(1):15-24.
101. Gaffke G, Gebauer B, Knollmann FD, et al. Use of semiflexible applicators for radiofrequency ablation of liver tumors. Cardiovasc Intervent Radiol 2006;29(2):270-275.
102. Stoeckelhuber BM, Leibecke T, Schulz E, et al. Radiation dose to the radiologist's hand during continuous CT fluoroscopy-guided interventions. Cardiovasc Intervent Radiol 2005;28(5):589-594.
103. Efstathopoulos EP, Brountzos EN, Alexopoulou E, et al. Patient radiation exposure measurements during interventional procedures: a prospective study. Health Phys 2006;91(1):36-40.
104. Larson AC, Wang D, Atassi B, et al. Transcatheter intraarterial perfusion: MR monitoring of chemoembolization for hepatocellular carcinoma - feasibility of initial clinical translation. Radiology 2008;246(3):964-971.
105. Kim CK, Choi D, Lim HK, et al. Therapeutic response assessment of percutaneous radiofrequency ablation for hepatocellular carcinoma: utility of contrast-enhanced agent detection imaging. Eur J Radiol 2005;56(1): 66-73.
106. Leyendecker JR, Dodd GD 3rd Halff GA, et al. Sonographically observed echogenic response during intraoperative radiofrequency ablation of cirrhotic livers: pathologic correlation. AJR Am J Roentgenol 2002;178(5):1147-1151.
107. Mala T, Aurdal L, Frich L, et al. Liver tumor cryoablation: a commentary on the need of improved procedural monitoring. Technol Cancer Res Treat 2004;3(1):85-91.
108. Permpongkosol S, Nielsen ME, Solomon SB. Percutaneous renal cryoablation. Urology 2006;68(1 suppl):19-25.
109. Bao A, Goins B, Dodd GD 3rd, et al. Realtime iterative monitoring of radiofrequency ablation tumor therapy with 15O-water PET imaging. J Nucl Med 2008;49(10):1723-1729.
110. de Senneville BD, Mougenot C, Quesson B, Dragonu I, Grenier N, Moonen CT. MR thermometry for monitoring tumor ablation. Eur Radiol 2007;17(9):2401-2410.
111. Dewey WC. Arrhenius relationships from the molecule and cell to the clinic. Int J Hyperthermia 1994;10(4):457-483.
112. Rieke V, Butts Pauly K. MR thermometry. J Magn Reson Imaging 2008;27(2):376-390.
113. McDannold N, Tempany CM, Fennessy FM, et al. Uterine leiomyomas: MR imaging-based thermometry and thermal dosimetry during focused ultrasound thermal ablation. Radiology 2006;240(1):263-272.
114. Boss A, Rempp H, Martirosian P, et al. Wide-bore 1.5 Tesla MR imagers for guidance and monitoring of radiofrequency ablation of renal cell carcinoma: initial experience on feasibility. Eur Radiol 2008;18(7): 1449-1455.
115. Seror O, Lepetit-Coiffé M, Le Bail B, et al. Real time monitoring of radiofrequency ablation based on MR thermometry and thermal dose in the pig liver in vivo. Eur Radiol 2008;18(2):408-416.
116. Vogl TJ, Straub R, Eichler K, Söllner O, Mack MG. Colorectal carcinoma metastases in liver: laser-induced interstitial thermotherapy - local tumor control rate and survival data. Radiology 2004;230(2): 450-458. (Pubitemid 38133806)
117. Mack MG, Straub R, Eichler K, Söllner O, Lehnert T, Vogl TJ. Breast cancer metastases in liver: laser-induced interstitial thermotherapy - local tumor control rate and survival data. Radiology 2004;233(2):400-409. (Pubitemid 39423798)
118. Liu H, Hall WA, Martin AJ, Maxwell RE, Truwit CL. MR-guided and MR-monitored neurosurgical procedures at 1.5 T. J Comput Assist Tomogr 2000;24(6):909-918.
119. Morikawa S, Inubushi T, Kurumi Y, et al. MR-guided microwave thermocoagulation therapy of liver tumors: initial clinical experiences using a 0.5 T open MR system. J Magn Reson Imaging 2002;16(5):576-583.
120. Okuda S, Kuroda K, Oshio K, et al. MR-based temperature monitoring for hot saline injection therapy. J Magn Reson Imaging 2000;12(2):330-338.
121. Quesson B, de Zwart JA, Moonen CT. Magnetic resonance temperature imaging for guidance of thermotherapy. J Magn Reson Imaging 2000;12(4):525-533.
122. Sapareto SA, Dewey WC. Thermal dose determination in cancer therapy. Int J Radiat Oncol Biol Phys 1984;10(6):787-800.
123. Fallone BG, Moran PR, Podgorsak EB. Non-invasive thermometry with a clinical x-ray CT scanner. Med Phys 1982;9(5):715-721.
124. Arthur RM, Straube WL, Trobaugh JW, Moros EG. Non-invasive estimation of hyperthermia temperatures with ultrasound. Int J Hyperthermia 2005;21(6):589-600.
125. Kim SH, Jung SE, Kim HL, Hahn ST, Park GS, Park WC. The potential role of dynamic MRI in assessing the effectiveness of high-intensity focused ultrasound ablation of breast cancer. Int J Hyperthermia 2010; 26:594-603.
126. Kim YS, Rhim H, Lim HK, et al. Completeness of treatment in hepatocellular carcinomas treated with image-guided tumor therapies: evaluation of positive predictive value of contrast-enhanced CT with histopathologic correlation in the explanted liver specimen. J Comput Assist Tomogr 2006;30(4):578-582.
127. Javadi S, Ahrar JU, Ninan E, Gupta S, Matin SF, Ahrar K. Characterization of contrast enhancement in the ablation zone immediately after radiofrequency ablation of renal tumors. J Vasc Interv Radiol 2010; 21(5):690-695.
128. Park MH, Rhim H, Kim YS, Choi D, Lim HK, Lee WJ. Spectrum of CT findings after radiofrequency ablation of hepatic tumors. RadioGraphics 2008;28(2):379-390; discussion 390-392.
129. Kawamoto S, Permpongkosol S, Bluemke DA, Fishman EK, Solomon SB. Sequential changes after radiofrequency ablation and cryoablation of renal neoplasms: role of CT and MR imaging. RadioGraphics 2007;27(2):343-355.
130. Lokken RP, Gervais DA, Arellano RS, et al. Inflammatory nodules mimic applicator track seeding after percutaneous ablation of renal tumors. AJR Am J Roentgenol 2007; 189(4):845-848.
131. Weight CJ, Kaouk JH, Hegarty NJ, et al. Correlation of radiographic imaging and histopathology following cryoablation and radio frequency ablation for renal tumors. J Urol 2008;179(4):1277-1281; discussion 1281-1283.
132. Choi BI, Kim HC, Han JK, et al. Therapeutic effect of transcatheter oily chemoembolization therapy for encapsulated nodular hepatocellular carcinoma: CT and pathologic findings. Radiology 1992;182(3):709-713.
133. Atassi B, Bangash AK, Bahrani A, et al. Multimodality imaging following 90Y radioembolization: a comprehensive review and pictorial essay. RadioGraphics 2008;28(1): 81-99.
134. Vossen JA, Buijs M, Kamel IR. Assessment of tumor response on MR imaging after locoregional therapy. Tech Vasc Interv Radiol 2006;9(3):125-132.
135. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors: European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000;92(3):205-216.
136. Merkle EM, Nour SG, Lewin JS. MR imaging follow-up after percutaneous radiofrequency ablation of renal cell carcinoma: findings in 18 patients during first 6 months. Radiology 2005;235(3):1065-1071.
137. Steinke K, King J, Glenn D, Morris DL. Radiologic appearance and complications of percutaneous computed tomography-guided radiofrequency-ablated pulmonary metastases from colorectal carcinoma. J Comput Assist Tomogr 2003;27(5):750-757.
138. Suh RD, Wallace AB, Sheehan RE, Heinze SB, Goldin JG. Unresectable pulmonary malignancies: CT-guided percutaneous radiofrequency ablation - preliminary results. Radiology 2003;229(3):821-829.
139. Bruix J, Sherman M, Llovet JM, et al. Clinical management of hepatocellular carcinoma: conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001;35(3): 421-430.
140. Choi H. Critical issues in response evaluation on computed tomography: lessons from the gastrointestinal stromal tumor model. Curr Oncol Rep 2005;7(4):307-311.
141. Choi H, Charnsangavej C, de Castro Faria S, et al. CT evaluation of the response of gastrointestinal stromal tumors after imatinib mesylate treatment: a quantitative analysis correlated with FDG PET findings. AJR Am J Roentgenol 2004;183(6):1619-1628.
142. Curran SD, Muellner AU, Schwartz LH. Imaging response assessment in oncology. Cancer Imaging 2006;6:S126-S130.
143. Lencioni R and Llovet JM. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis 2010;30:52-60.
144. Bricault I, Kikinis R, Morrison PR, Vansonnenberg E, Tuncali K, Silverman SG. Liver metastases: 3D shape-based analysis of CT scans for detection of local recurrence after radiofrequency ablation. Radiology 2006; 241(1):243-250.
145. Frich L, Hagen G, Brabrand K, et al. Local tumor progression after radiofrequency ablation of colorectal liver metastases: evaluation of ablative margin and three-dimensional volumetric analysis. J Vasc Interv Radiol 2007;18(9):1134-1140.
146. Kamel IR, Bluemke DA, Eng J, et al. The role of functional MR imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinoma. J Vasc Interv Radiol 2006;17(3):505-512.
147. Assumpcao L, Choti M, Pawlik TM, Gecshwind JF, Kamel IR. Functional MR imaging as a new paradigm for image guidance. Abdom Imaging 2009;34(6):675-685.
148. Koh DM, Collins DJ. Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol 2007;188(6):1622-1635.
149. Chen CY, Li CW, Kuo YT, et al. Early response of hepatocellular carcinoma to transcatheter arterial chemoembolization: choline levels and MR diffusion constants-initial experience. Radiology 2006;239(2):448-456.
150. Kim CK, Park BK, Lee HM, Kim SS, Kim E. MRI techniques for prediction of local tumor progression after high-intensity focused ultrasonic ablation of prostate cancer. AJR Am J Roentgenol 2008;190(5):1180-1186.
151. Boss A, Martirosian P, Schraml C, et al. Morphological, contrast-enhanced and spin labeling perfusion imaging for monitoring of relapse after RF ablation of renal cell carcinomas. Eur Radiol 2006;16(6):1226-1236.
152. Meloni MF, Bertolotto M, Alberzoni C, et al. Follow-up after percutaneous radiofrequency ablation of renal cell carcinoma: contrast-enhanced sonography versus contrast-enhanced CT or MRI. AJR Am J Roentgenol 2008;191(4):1233-1238.
153. Willmann JK, Lutz AM, Paulmurugan R, et al. Dual-targeted contrast agent for US assessment of tumor angiogenesis in vivo. Radiology 2008;248(3):936-944.
154. Wahl RL, Jacene H, Kasamon Y, Lodge MA. From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors. J Nucl Med 2009;50(suppl 1): 122S-150S.
155. Langenhoff BS, Oyen WJG, Jager GJ, et al. Efficacy of fluorine-18-deoxyglucose positron emission tomography in detecting tumor recurrence after local ablative therapy for liver metastases: a prospective study. J Clin Oncol 2002;20(22):4453-4458.
156. van Waarde A, Jager PL, Ishiwata K, Dierckx RA, Elsinga PH. Comparison of sigma-ligands and metabolic PET tracers for differentiating tumor from inflammation. J Nucl Med 2006;47(1):150-154.
157. Brouwers A, Mulders P, Oosterwijk E, et al. Pharmacokinetics and tumor targeting of 131I-labeled F(ab')2 fragments of the chimeric monoclonal antibody G250: preclinical and clinical pilot studies. Cancer Biother Radiopharm 2004;19(4):466-477.
158. Holland JP, Caldas-Lopes E, Divilov V, et al. Measuring the pharmacodynamic effects of a novel Hsp90 inhibitor on HER2/neu expression in mice using Zr-DFO-trastuzumab. PLoS ONE 2010;5(1):e8859.